Company intelligence / Profile preview

REM Analytics

Monthey, Valais, Switzerlandremanalytics.ch ↗

Ownership: Private
Employees: ~6
Development stage: Commercial

Overview

REM Analytics has developed a proprietary technology platform for advanced microbiome diagnostics, enabling accurate, fast, and cost-effective testing. Their solutions have been clinically validated in areas such as women’s health and child nutrition. The company offers both research services and commercial diagnostic products.

Therapeutic areas: GastroenterologyEndocrinologyImmunology
Modalities: Microbiome diagnosticsDNA analysisProbiotic strain tracking
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on REM Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on REM Analytics.

Explore the full profile